Clot-Specific Streptokinase - The Third Generation Clot Buster

Process for production of clot specific streptokinase which can work without unwanted proteolytic degradation of clotting factors.

Process for the production of clot specific streptokinase which dissolve the pathological blood clot without plasminogen activation.

A clot-buster drug with minimal side effects has been highly desirable.
This function i.e. the ability to dissolve the pathological blood clot without plasminogen activation through the circulatory system is  a highly coveted and premium property in any clot buster drug of choice.